Current Health raises £31m in Series B funding led by Northpond Ventures to expand internationally
The Series B round was led by Northpond Ventures to support international growth.
Current Health operates an enterprise remote care management platform that monitors and manages patient health in the home. The system integrates data from various monitoring devices to help health systems and pharmaceutical companies deliver care outside clinical settings.
Current Health has secured £31m in Series B financing to accelerate its global expansion. The investment round was led by Northpond Ventures, with participation from LRVHealth, OSF HealthCare, Section 32, Elements Health Ventures, and existing backers. The fresh capital follows a period of rapid revenue growth as the company scales its platform for remote patient management.
From the founder
"In the next 5 years, we’ll see a majority of healthcare services delivered in a patient’s home, with the hospital reserved for intensive care, trauma, and surgery"
Chris McCann
CEO and Co-Founder at Current Health
Investor perspective
"It’s rare to see a company successfully execute across both healthcare delivery and drug delivery – this is what makes Current Health so special"
Andrea Jackson
Director, Northpond Ventures
Use of funds
- 01Expand into international markets
Investors
Andrea Jackson
Northpond Ventures
Tripp Peake
LRVHealth
Stan Lynall
OSF HealthCare
Andy Harrison
Section 32
Elements Health Ventures
Categories
About the company
Current Health
Enterprise remote care management platform for home-based patient monitoring.